Back to 3-year outcome after the RIOTT trial

3-year outcome after the RIOTT trial

First published: 13 March 2019 | Last updated: 28 March 2019

{alt_text}

Dr Nicola Metrebian

Senior Research Fellow

Senior Research Fellow in Addictions at the National Addiction Centre (King’s College London) and Senior Advisor at the National Institute for Health Research (NIHR) Research Design Service (RDS), London. Background in psychology and received her PhD from Imperial College London examining influences on the prescribing of heroin for the treatment of opiate dependence in the UK. She has 20 years in addiction research undertaking clinical RCTS in pharmacological and psychological interventions for opiate dependence including evaluating supervised injectable opiate treatment for hard to treat heroin users (RIOTT). Received a European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Scientific Paper award and the King’s Award for Research Project of the Year.  Has over 30 publications including many on heroin prescribing treatment.

 

Report Author

Dr Nicola Metrebian

Senior Research Fellow


Dr Nicola Metrebian is a Senior Research Fellow in Addictions at King’s College London. She has 20 years in addiction research undertaking large clinical RCTS to assess the effectiveness of pharmacological and behavioural interventions for opiate users. Her research has included evaluating supervised heroin treatment for hard to treat heroin users (RIOTT), assessing the effectiveness of contingency management (positive reinforcement using financial incentives) in encouraging the completion of hepatitis B vaccination and in improving treatment outcomes for opiate users receiving opiate substitution treatment. She is currently researching the use of mobile telephones to deliver behavioural interventions.

Read Full Biography